The changes in SP expression within the ENS have been noted in parasite infection [15], carcinoma [16] and inflammatory bowel disease [17], while the changes in the number of GAL-like immunoreactive (LI) enteric nervous structures have been recorded after bisphenol A supplementation [18] and experimentally induced ileal hypertrophy [19]. This evidence concerns the gene GAL and inflammatory bowel disease.